Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E‑deficient mice
Xianjing Wei(Affiliated Zhongshan Hospital of Dalian University), Xiaoqing Wang(Luoyang Orthopedic-Traumatological Hospital of Henan Province)
Cited by 24
Related Papers
Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders
|Journal for ImmunoTherapy of Cancer|2022|51
CLI-095 decreases atherosclerosis by modulating foam cell formation in apolipoprotein E-deficient mice
|Molecular Medicine Reports|2016|17
PPARδ agonist protects against osteoarthritis by activating AKT/mTOR signaling pathway-mediated autophagy
|Frontiers in Pharmacology|2024|4
<i>In Vivo</i> CRISPR Screens Identify E3 Ligase Cop1 as a Modulator of Macrophage Infiltration and Cancer Immunotherapy Target
|bioRxiv (Cold Spring Harbor Laboratory)|2020|1